DIN 02529343 — LAPELGA 6 MG
LAPELGA is a solution of Pegfilgrastim marketed by APOTEX INC. The full Pegfilgrastim monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02529343
- Brand name
- LAPELGA
- Active ingredient
- Pegfilgrastim
- Strength
- 6 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Hematopoietic agent (granulocyte colony-stimulating factor analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pegfilgrastim products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02484153 | FULPHILA | 10 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02474565 | LAPELGA | 6 MG | SOLUTION | APOTEX INC | MARKETED |
| 02249790 | NEULASTA | 10 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02546973 | NIOPEG | 6 MG | SOLUTION | NORA PHARMA INC | MARKETED |
| 02506238 | NYVEPRIA | 6 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02553945 | PEXEGRA | 10 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02497395 | ZIEXTENZO | 6 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |